CARPL provides a radiology AI platform that simplifies the integration, validation, and deployment of AI solutions within radiology departments. It offers access to over 110 AI applications from various vendors, enabling integration with existing PACS and RIS systems. The platform is designed to support scalable AI deployments, streamline workflows, and enhance diagnostic accuracy by providing a unified interface for managing AI solutions across different radiology tasks.

Cleerly is an AI-based digital care platform for the diagnosis of heart disease. It utilizes coronary computed tomography angiography (CCTA) to provide analyses of atherosclerosis, plaque buildup and stenosis, through machine learning algorithms. The technology creates 3D models of coronary arteries for early heart disease detection and treatment plans. It includes the Cleerly Proxy and Cleerly ISCHEMIA for coronary artery disease.

LumineticsCore by Digital Diagnostics is an AI diagnostic system that autonomously detects diabetic retinopathy, including macular edema, at the point-of-care using fundus images captured by a trained operator. It provides rapid results without needing specialist review, which facilitates immediate care decisions and referrals if disease is detected. The system is designed for healthcare providers, eye care professionals, payors, and patients, enhancing access to diagnostic evaluations for people with diabetes.

Lunit is an AI software company developing advanced solutions for cancer diagnostics and therapeutics. Their products include Lunit INSIGHT CXR, which analyzes chest X-rays to detect abnormalities and Lunit INSIGHT MMG for breast cancer detection by reducing false positives. Lunit SCOPE IO and SCOPE PD-L1 enhance the precision of immunotherapy, analyzing cancer tissue samples to predict treatment response.

Paige offers an AI-powered digital pathology platform designed to assist pathologists in diagnosing cancer and other diseases from pathology slides. The platform includes tools for detecting, quantifying, and visualizing tumor areas, providing decision support and streamlining workflows. Paige's AI models are trained on large datasets of pathology images and integrate with existing lab systems to enhance diagnostic accuracy and efficiency in clinical settings.

Qure.ai develops AI-based healthcare solutions primarily for interpreting medical imaging, such as X-rays, CT scans, and MRIs. Their tools include qXR for detecting abnormalities in chest X-rays and qER for analyzing head CT scans for conditions like bleeds and fractures. The AI models are designed to support early diagnosis, expedite treatment pathways, and improve radiology workflows. Qure.ai's technology is used in clinical settings globally for applications in lung cancer screening, stroke management, and TB detection.

Rad AI Continuity helps automate radiology reporting and follow-up workflows. It integrates with PACS and RIS systems to generate radiologist impressions and manages patient follow-ups by tracking critical findings and ensuring that appropriate care is scheduled. This tool is used to improve radiology department efficiency, minimize missed follow-ups, and improve patient outcomes through better management of imaging results.

Rad AI Reporting is an AI-powered tool that automates the generation of radiology reports by analyzing imaging data and integrating it with PACS and RIS systems. It assists radiologists by automatically creating impressions based on findings, which can be edited before finalization. This helps reduce the time spent on report creation, ensuring consistent, high-quality output while allowing radiologists to focus on complex cases.

RapidAI develops AI-driven imaging solutions primarily for stroke, trauma, and vascular conditions. Its tools analyze brain scans, such as CT and MRI images, to assist physicians in diagnosing and treating conditions like stroke and subdural hematomas. The company's platform helps expedite treatment decisions by providing results within minutes, and it integrates into hospital systems via PACS and mobile apps. RapidAI has received FDA clearances for various modules, including those for detecting intracranial hemorrhages and subdural hematomas, making it a key tool in emergency neurovascular care.

Sirona Medical's RadOS unifies radiology workflows, combining a diagnostic viewer, reporting, PACS/archive, and AI tools into a single system accessible via any browser. It offers features like hybrid rendering for fast image processing, voice-driven commands, and AI-enhanced reporting that integrates directly with images.

Tempus Oncology is a precision medicine company that leverages AI and vast clinical and molecular data to support oncologists in making data-driven treatment decisions. Its offerings include comprehensive genomic profiling, minimal residual disease (MRD) testing, and AI-powered solutions like Tempus ONE, a voice-enabled device providing real-time access to patient data and clinical insights. The Tempus Next platform uses AI to optimize care pathways and close clinical gaps by analyzing EHR, imaging, and molecular data. Additionally, Tempus provides clinical trial matching and collaborates extensively with biopharma for drug discovery and research.

Viz.ai leverages artificial intelligence to automate detection of abnormalities in medical imaging, such as strokes, and facilitate rapid communication between clinicians. Viz.ai streamlines analyzes images and alerts relevant providers to enable faster decision-making. The platform is particularly useful in acute care settings, such as emergency departments and stroke centers, where time-sensitive diagnosis and intervention are critical.